Study of Safety and Efficacy of Mometasone Furoate Used in Combination With Formoterol Fumarate Compared With Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

Condition:   Asthma
Interventions:   Drug: MK-0887A 100/10 mcg;   Drug: MK-0887 100 mcg;   Drug: Albuterol/Salbutamol;   Drug: Prednisone/Prednisolone
Sponsor:   Merck Sharp & Dohme Corp.
Not yet recruiting – verified April 2016

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

CLINICAL PHARMACOLOGY STUDY OF A FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 50µg PLUS FORMOTEROL FUMARATE 6 µg VERSUS THE FREE COMBINATION OF BECLOMETHASONE HFA pMDI AND FORMOTEROL HFA pMDI AVAILABLE ON THE MARKET USING THE AEROCHAMBER PLUS™ SPACER DEVICE IN ASTHMATIC CHILDREN

Condition:   Asthma
Interventions:   Drug: CHF1535 pMDI + AC Plus;   Drug: BDP and Formoterol + AC Plus
Sponsors:   Chiesi Farmaceutici S.p.A.;   Chiesi Farmaceutici S.p.A.
Completed – verified April 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)Long-Term Study Shows … – MarketWatch (press release)

SYMBICORT(R) (budesonide/formoterol fumarate dihydrate)Long-Term Study Shows
MarketWatch (press release)
More than 22 million Americans are living with asthma, including 2.3+ million African Americans. "These findings provide important information about the use of SYMBICORT in African-American patients with persistent asthma, and may help guide healthcare
AstraZeneca (AZN) Says SYMBICORT Shows Similar Safety Profile to Budesonide in StreetInsider.com (subscription)

all 4 news articles »

View full post on asthma – Google News